Lv1
20 积分 2026-07-25 加入
Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease
1天前
已完结
MASLD and the Cardiovascular-Kidney-Liver-Metabolic syndrome
4天前
已完结
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management
9天前
已完结
Research advances in the diagnosis and treatment of MASLD/MASH
9天前
已完结
皖公网安备34019202002308
